Project Description
NovoGenomics is one of the few Saudi biotech start-ups tackling the challenges of preventative medicine through clinical assessment of genomics and multi-omics. NovoGenomics aspires to localize the field of clinical medicine and agrigenomics by applying advanced technologies in the mining and analysis of data. NovoGenomics plans to advance the health and wellness industry by focusing its efforts towards preventative care prior to the onset of symptomatic disease.
Advisory
STF consulted and worked closely with the NovoGenomics founding team to best navigate the launch period and build viable brand awareness to gain competitive market share. Biotech locally is dominated primarily by international companies, which added a layer of complexity in the brand strategy positioning assessment. Upon extensive research calibrated by international benchmarking, our expert team provided sound consultations towards the strategic approach of brand messaging, philosophy and growth trajectory.
Agency
NovoGenomics’s purpose is to influence behavioural changes in patients and customers when it relates to preventative testing and genetic assessments, which is often initiated through a strong brand identity. STF creatively approached the challenge of representing a biotech start-up by developing a modern vibrant logo with a unique color scheme. The brand identity was then replicated across multiple mediums of marketing collateral to relate to the wide target audience, starting with their prenatal testing campaign aimed at young mothers and mothers-to-be.
Advisory
Social Media Development & Management
Agency
Brand Applications & Guidelines
